First Time Loading...

Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 9.99 USD 0.3% Market Closed
Updated: Mar 28, 2024

Accolade Inc
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Accolade Inc
Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
Revenue
$363.1m
CAGR 3-Years
40%
CAGR 5-Years
36%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Revenue
$12.1B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Revenue
$9.3B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Revenue
$357.8B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
11%
Cigna Corp
NYSE:CI
Revenue
$195.3B
CAGR 3-Years
7%
CAGR 5-Years
32%
CAGR 10-Years
20%
Laboratory Corporation of America Holdings
NYSE:LH
Revenue
$12.2B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
8%

Accolade Inc
Revenue Breakdown

Breakdown by Geography
Accolade Inc

Not Available

Breakdown by Segments
Accolade Inc

Total Revenue: 363.1m USD
100%
Access Fees: 284.1m USD
78.3%
Utilization-Based Fees: 79m USD
21.8%

See Also

What is Accolade Inc's Revenue?
Revenue
363.1m USD

Based on the financial report for Feb 28, 2023, Accolade Inc's Revenue amounts to 363.1m USD.

What is Accolade Inc's Revenue growth rate?
Revenue CAGR 5Y
36%

Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Accolade Inc have been 40% over the past three years , 36% over the past five years .